Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - CAPITAL EXPENDITURES
Capital Expenditures RGNX - REGENXBIO Inc.
-9.96 M
LAST VALUE
65.60%
2 YEAR CAGR
5.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR